Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

BioStem Technologies

Biotech & Life Sciences · Pompano Beach, United States · Founded 2006 · IPO 2008 Thoroughbred

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies

Valuation
$52M
Market cap · May/2026
Revenue
$302M
Latest reported FY
EBITDA
$31M
Latest reported FY

Global footprint

Where BioStem Technologies has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States97%
🇲🇩 Moldova3%
🇵🇭 Philippines2.7%
3 countries shown
Web traffic by country
3K monthly visits
across markets
🇺🇸 United States110%
🇮🇳 India10%
Top 2 markets shown

Market sentiment

What the market is saying about BioStem Technologies

An AI-synthesized read of the highest-engagement posts about BioStem Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioStem Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.